Volitionrx (VNRX) Research & Development (2011 - 2026)
Volitionrx's (VNRX) quarterly Research & Development came in at $2.5 million in Q4 2025, down 4.37% YoY from $2.6 million in Q4 2024, and up 157.48% on a QoQ basis from $958567.0 in Q3 2025.
Volitionrx (VNRX) Research & Development (2011 - 2026) Analysis & Trends
Volitionrx (VNRX) has 11 years of Research & Development data on file, last reported at $2.5 million in Q4 2025.
- Quarterly Research & Development fell 4.37% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.8 million (down 26.92% YoY) and the FY2025 annual result came in at $10.1 million, down 29.99% from the prior year.
- Research & Development improved to $2.5 million in Q4 2025, from $958567.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $5.5 million in Q2 2023 to a low of -$8.2 million in Q4 2023.
- A 5-year average of $1.6 million and a median of $2.1 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development surged 1259.82% — and 2023, when it plunged 297.68%.
- Tracing VNRX's Research & Development over 5 years: stood at -$6.0 million in 2021, then surged by 168.85% to $4.1 million in 2022, then sank by 297.68% to -$8.2 million in 2023, then soared by 131.61% to $2.6 million in 2024, then slipped by 4.37% to $2.5 million in 2025.
- The last three Research & Development figures came in at $2.5 million (Q4 2025), $958567.0 (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Volitionrx | 1.20 Mn | -1.59 Mn | - | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 958,567.00 |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | -8.16 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 5.45 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | -6.00 Mn |
| Sep 30, 2021 | 836,655.00 |
| Jun 30, 2021 | 2.94 Mn |